PharmAust: New Drug Entering Phase 2 Trials Targeting Multiple Cancers

Dec. 30, 2015
Dave Gentry, host of "The RedChip Money Report", interviews Dr. Roger Aston, Executive Chairman of PharmAust Ltd (ASX: PAA). PharmAust Limited (“PAA,” ...

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market